קם-רהו די

Country: Израел

Језик: Хебрејски

Извор: Ministry of Health

Активни састојак:

ANTI-D IMMUNOGLOBULINS

Доступно од:

KAMADA LTD, ISRAEL

АТЦ код:

J06BB01

Фармацеутски облик:

תמיסה להזרקה

Састав:

ANTI-D IMMUNOGLOBULINS 150 MCG / 1 ML

Пут администрације:

תוך-ורידי

Тип рецептора:

מרשם נדרש

Произведен од:

KAMADA LTD, ISRAEL

Терапеутска група:

ANTI-D (RH) IMMUNOGLOBULIN

Терапеутска област:

ANTI-D (RH) IMMUNOGLOBULIN

Терапеутске индикације:

Suppression of Rh immunization in non-sensitized Rho(D) negative women delivering an Rh positive baby, or when the baby's Rh type is unknown. Suppression of Rh immunization after spontaneous or induced abortions, threatened abortion associated with maternal bleeding amniocentesis, chorionic villus sampling ruptured tubal pregnancy, and significant abdominal trauma. KAM-Rho should be given within 72 hours of event. Immune thrombocytopenic purpura (ITP): Rho (d)-positive adults with chronic ITP, children with chronic or acute ITP, and patients with Thrombocytopenia secondary to HIV infection in clinical situations requiring an increase in platelet count to prevent excessive hemorrhage.

Датум одобрења:

2013-03-31